Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.20    -1.80 (-2.65%)
Bid:
65.90
Ask:
66.70
Spread: 0.80 (1.214%)
Market Cap: £584.83m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Transaction in Own Shares

30 Sep 2025 07:00

RNS Number : 2832B
IP Group PLC
30 September 2025
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme, an extension to which was announced on 26 June 2025 (the Buyback Programme).

Date of purchase:

29/09/2025

Number of ordinary shares purchased:

349,003

Highest price paid per ordinary share (GBp):

53.70

Lowest price paid per ordinary share (GBp): 

52.80

Volume weighted average price paid per ordinary share (GBp): 

53.1427

 

Any Ordinary Shares purchased under the Buyback Programme will be cancelled in order to decrease the number of Ordinary Shares in issue. Accordingly, following the above transaction and subsequent cancellation of the Repurchased Shares, the Group has 896,025,905 ordinary shares in issue with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules. There are no Ordinary Shares held in treasury.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

29/09/2025

Number of ordinary shares purchased:

349,003

Volume weighted average price (pence):

53.1427

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

8104

53.00

 08:23:19

XLON

7371

53.00

 08:23:25

XLON

7866

53.10

 08:24:52

XLON

7568

53.00

 08:24:52

XLON

6524

53.00

 08:29:55

XLON

6554

52.90

 08:29:55

XLON

7538

53.50

 08:43:17

XLON

7559

53.50

 08:46:52

XLON

7709

53.40

 08:57:05

XLON

2265

53.40

 08:57:05

XLON

4500

53.40

 08:57:05

XLON

382

53.50

 09:28:37

XLON

1159

53.50

 09:28:37

XLON

1541

53.50

 09:28:37

XLON

1541

53.50

 09:28:37

XLON

466

53.50

 09:28:37

XLON

194

53.50

 09:28:37

XLON

1247

53.60

 09:33:43

XLON

6465

53.60

 09:33:43

XLON

5874

53.60

 09:56:20

XLON

476

53.60

 09:56:20

XLON

7854

53.50

 09:56:24

XLON

3706

53.70

 11:29:55

XLON

143

53.70

 11:29:55

XLON

2986

53.70

 11:32:52

XLON

6771

53.70

 11:32:52

XLON

8102

53.70

 11:32:52

XLON

2677

53.50

 11:33:57

XLON

143

53.50

 12:10:29

XLON

143

53.50

 12:10:29

XLON

6537

53.50

 12:10:29

XLON

4286

53.50

 12:10:29

XLON

6385

53.40

 12:48:29

XLON

559

53.40

 12:48:29

XLON

7226

53.30

 13:15:47

XLON

6944

53.30

 13:15:47

XLON

92

53.20

 13:46:47

XLON

143

53.20

 13:46:47

XLON

8008

53.20

 13:49:35

XLON

2608

53.20

 13:49:35

XLON

4235

53.20

 13:49:35

XLON

1082

53.00

 13:52:56

XLON

6579

53.20

 14:09:03

XLON

1894

53.10

 14:09:14

XLON

7713

53.10

 14:12:51

XLON

4685

53.10

 14:12:51

XLON

2111

53.20

 14:34:03

XLON

408

53.20

 14:34:03

XLON

4556

53.20

 14:34:03

XLON

1945

53.10

 14:35:26

XLON

5061

53.10

 14:35:26

XLON

2466

53.10

 14:35:26

XLON

4725

53.10

 14:35:26

XLON

3544

52.90

 14:40:43

XLON

4500

52.90

 14:40:43

XLON

6676

52.80

 14:59:58

XLON

7105

52.80

 15:01:20

XLON

3523

52.80

 15:06:20

XLON

4500

52.80

 15:06:20

XLON

8095

52.80

 15:12:00

XLON

608

52.80

 15:20:06

XLON

11645

52.90

 15:35:09

XLON

4759

52.90

 15:35:09

XLON

5500

52.90

 15:35:09

XLON

6721

52.90

 15:35:09

XLON

5

52.90

 15:43:09

XLON

1000

52.90

 15:43:09

XLON

1306

52.90

 15:43:09

XLON

847

52.90

 15:43:09

XLON

1088

52.90

 15:43:09

XLON

2756

52.90

 15:43:09

XLON

7538

52.90

 15:43:09

XLON

1060

52.90

 15:50:09

XLON

2134

52.90

 15:50:09

XLON

3563

52.90

 15:50:09

XLON

855

52.90

 15:50:09

XLON

3568

52.90

 15:52:09

XLON

960

52.90

 15:52:09

XLON

17315

52.90

 16:00:36

XLON

4762

52.90

 16:09:56

XLON

2665

52.90

 16:10:18

XLON

6688

52.90

 16:13:18

XLON

862

52.90

 16:15:18

XLON

1825

52.90

 16:15:19

XLON

100

52.90

 16:15:19

XLON

101

52.90

 16:16:09

XLON

4117

52.90

 16:18:04

XLON

1036

52.90

 16:18:37

XLON

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGZLVLMGKZM
Date   Source Headline
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.